When addressing the Food and Drug Administration’s (FDA) reluctancy to develop new regulations for cannabidiol (CBD), FDA Commissioner Robert Califf…
Some patients that have recovered from a COVID-19 infection experience what the CDC has termed “long-COVID”. Long-COVID is a condition…
In its 2023 Notice of Benefit and Payment Parameters Proposed Rule (2023 NBPP), the U.S. Department of Health and Human…
On April 13, the Food and Drug Administration published a draft guidance on “Diversity Plans to Improve Enrollment of Participants…
On April 5, 2022, the Biden Administration announced that the Treasury Department and the Internal Revenue Service (IRS) proposed a…
Support for telehealth expansion is growing both on and off the Hill, but members of Congress disagree on whether this…
Prescription digital therapeutics (PDTs) are evidence-based medical interventions using software that can be accessed on a tablet or smartphone to…
On December 31, 2021, New York Governor Kathy Hochul signed S.3672/A.1396 which will require pharmacy benefit managers (PBMs) to be…
On December 29, 2021, the California Department of Health Care Services (DHCS) announced that a California State’s Medicaid (Medi-Cal) pilot…
On September 21, 2021, Senators Wyden and Crapo asked interested stakeholders to submit comments on evidence-based solutions and ideas to improving mental…